You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 7, 2025

Drug Price Trends for NDC 00310-7370


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00310-7370

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
BUDESONIDE 160MCG/FORMOTEROL FUM 4.5MCG/SPRAY Prasco, LLC 00310-7370-20 10.2GM 250.06 24.51569 2024-01-01 - 2026-06-30 FSS
BUDESONIDE 160MCG/FORMOTEROL FUM 4.5MCG/SPRAY Prasco, LLC 00310-7370-20 10.2GM 164.16 16.09412 2021-07-01 - 2026-06-30 Big4
BUDESONIDE 160MCG/FORMOTEROL FUM 4.5MCG/SPRAY Prasco, LLC 00310-7370-20 10.2GM 250.06 24.51569 2021-07-01 - 2026-06-30 FSS
BUDESONIDE 160MCG/FORMOTEROL FUM 4.5MCG/SPRAY Prasco, LLC 00310-7370-20 10.2GM 154.48 15.14510 2022-01-01 - 2026-06-30 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 0310-7370

Introduction

The drug with the National Drug Code (NDC) 0310-7370 is Budesonide and Formoterol Fumarate Dihydrate aerosol, a combination medication used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Here, we will delve into the market analysis and price projections for this medication.

Drug Overview

Budesonide and Formoterol Fumarate Dihydrate aerosol is a prescription inhaler that combines a corticosteroid (budesonide) and a long-acting beta2-adrenergic agonist (formoterol fumarate dihydrate). It is marketed by AstraZeneca Pharmaceuticals LP and is authorized as a generic under the New Drug Application (NDA) pathway[1].

Market Trends

The market for inhalers, particularly metered dose inhalers (MDIs), has seen significant trends in recent years.

Growth in MDI Sales

Historical data indicates that MDI sales have increased, with an estimated growth rate of approximately 1% per year from 2020 to 2025, aligned with population growth[4].

Impact of Environmental Regulations

The use of hydrofluorocarbons (HFCs) in MDIs has been a focus due to environmental concerns. However, HFC MDIs are not expected to be completely replaced by non-HFC alternatives in the near future, suggesting a stable market for HFC-based MDIs like Budesonide and Formoterol Fumarate Dihydrate aerosol[4].

Price Projections

General Drug Price Inflation

The overall drug price inflation rate for pharmaceuticals is projected to be around 3.81% in 2025, according to Vizient's summer Pharmacy Market Outlook. This inflation is driven by various factors, including the expansion of indications for previously approved medications and the introduction of high-cost therapies[3].

Specific Pricing for NDC 0310-7370

While specific price data for NDC 0310-7370 is not readily available, we can infer from general trends. For inhalers, prices can fluctuate based on market demand, competition from generic or alternative products, and regulatory changes.

Historical Pricing Context

For other medications, significant price increases have been observed. For example, generic drugs have seen median price increases of 19.9%, while brand-name drugs have seen median increases of 13.4%[5]. However, these figures are not directly applicable to NDC 0310-7370 without specific data.

Factors Influencing Pricing

Regulatory Environment

Price transparency and regulatory oversight play crucial roles in drug pricing. Programs like the Oregon Drug Price Transparency Program aim to provide insights into the factors influencing drug prices, including coupons, discounts, fees, and rebates. These factors can impact the final cost to consumers[5].

Market Competition

The presence of generic versions and alternative treatments can influence pricing. As more generic options become available, prices may decrease due to increased competition.

Supply Chain Dynamics

The pharmaceutical supply chain, including manufacturing costs, distribution fees, and markups, can significantly affect the final price of the drug. Understanding these dynamics is crucial for accurate price projections[5].

Industry Expert Insights

Industry experts emphasize the importance of integrating new therapies into standard care protocols, which can alter the future incidence of conditions like myocardial infarction and stroke. This integration can also impact drug pricing as demand and usage patterns change[3].

Statistics and Data

  • Sales Growth: MDI sales increased by 75% from 80 million units to 140 million units between 2015 and 2018[4].
  • Price Inflation: The projected overall drug price inflation rate for 2025 is 3.81%[3].
  • Regulatory Impact: The Oregon Drug Price Transparency Program reported a median price increase of 19.9% for generic drugs and 13.4% for brand-name drugs in 2022[5].

Conclusion

The market analysis for Budesonide and Formoterol Fumarate Dihydrate aerosol (NDC 0310-7370) indicates a stable demand driven by the ongoing need for effective treatments for asthma and COPD. While specific price projections are not available, the general trend of drug price inflation and the factors influencing pricing suggest that prices may rise modestly in line with overall pharmaceutical inflation rates.

Key Takeaways

  • Stable Demand: The market for MDIs, including Budesonide and Formoterol Fumarate Dihydrate aerosol, is expected to remain stable.
  • Price Inflation: General drug price inflation rates are projected at 3.81% for 2025.
  • Regulatory Impact: Price transparency and regulatory oversight are crucial in understanding and managing drug prices.
  • Market Competition: The presence of generic and alternative treatments can influence pricing.
  • Supply Chain Dynamics: Understanding the pharmaceutical supply chain is essential for accurate price projections.

FAQs

Q: What is the primary use of Budesonide and Formoterol Fumarate Dihydrate aerosol? A: It is used for the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Q: Who is the manufacturer of this drug? A: The drug is manufactured by AstraZeneca Pharmaceuticals LP.

Q: What is the projected drug price inflation rate for 2025? A: The projected overall drug price inflation rate for 2025 is 3.81%.

Q: How does the regulatory environment impact drug pricing? A: Regulatory programs aim to increase transparency and oversight, which can help in understanding and managing drug prices.

Q: What factors influence the pricing of pharmaceuticals like Budesonide and Formoterol Fumarate Dihydrate aerosol? A: Factors include market demand, competition, regulatory changes, supply chain dynamics, and overall drug price inflation rates.

Sources

  1. DailyMed: Budesonide and Formoterol Fumarate Dihydrate aerosol.
  2. DrugPatentWatch: Latest drug prices and trends.
  3. Vizient Inc.: Pharmacy Market Outlook.
  4. EPA: Market Characterization of the U.S. Metered Dose Inhaler Industry.
  5. Oregon Drug Price Transparency Program: Annual Report 2022.

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.